Study of ZIO-201 in Advanced Sarcoma

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ziopharm
• Treatments: Ifosfamide

Criteria

Metastatic and /or unresectable disease state after previous standard chemotherapy